LINDSEY SMAIL: Open Payments
NPI 1740439454 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,545 in 156 payments from 20 companies in 2025. Trend: 2023 $2,151 · 2024 $7,028 · 2025 $3,545
Food & beverage: $3,045Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $769 |
| Journey Medical Corporation | 2 | $523 |
| Galderma Laboratories, L.P. | 22 | $425 |
| UCB, Inc. | 17 | $316 |
| Lilly USA, LLC | 15 | $272 |
| LEO Pharma Inc. | 3 | $207 |
| Novartis Pharmaceuticals Corporation | 11 | $190 |
| Janssen Biotech, Inc. | 19 | $188 |
| Organon LLC | 4 | $163 |
| GENZYME CORPORATION | 4 | $130 |
Products named: RINVOQ, NEMLUVIO, Bimzelx, SKYRIZI, EBGLYSS, TREMFYA, DUPIXENT, VTAMA.
Industry payments across PA — which companies pay providers there.
